Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Cardiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Iran Biomed J. 2021 Mar 1;25(2):117-31. doi: 10.29252/ibj.25.2.117. Epub 2021 Jan 13.
The significance of cTfh cells and their subsets in atherosclerosis is not well understood. We measured the frequency of cTfh subsets in patients with different degrees of stenosis using flow-cytometry.
Participants included high (≥50%; n = 12) and low (<50%; n = 12) stenosis groups, as well as healthy controls (n = 6).
The frequency of CCR7loPD-1hiefficient-cTfh was significantly higher in patients with high stenosis compared to healthy controls (p = 0.003) and correlated with low-density lipoprotein (LDL; p = 0.043), cholesterol (p = 0.043), triglyceride (p = 0.019), neutrophil count (p = 0.032), platelet count (p = 0.024), neutrophil/lymphocyte ratio (NLR; p = 0.046), and platelet/lymphocyte ratio (PLR; p = 0.025) in high stenosis group. The frequency of CCR7hiPD-1lo quiescent-cTfh was higher in healthy controls compared to the high-stenosis group (p = 0.001) and positively correlated with high-density lipoprotein (p = 0.046). The frequency of efficient-cTfh cells was correlated with platelet count (p = 0.043), NLR (p = 0.036), and PLR (p P = 0.035) in low-stenosis group, while that of quiescent-cTfh cells was negatively correlated with LDL (p = 0.034), cholesterol (p = 0.047), platelet count (p = 0.032), and PLR (p = 0.041).
High percentages of cTfh and efficient-cTfh cells in patients with advanced atherosclerosis and their correlation with dyslipidemia and white blood cell counts suggest an ongoing cTfh subset deviation, towards efficient phenotype in the milieu of inflammation and altered lipid profile. Efficient cTfh cells have an effector phenotype and could in turn contribute to atherosclerosis progression.
cTfh 细胞及其亚群在动脉粥样硬化中的意义尚不清楚。我们使用流式细胞术测量了不同狭窄程度患者的 cTfh 亚群频率。
参与者包括高(≥50%;n=12)和低(<50%;n=12)狭窄组以及健康对照组(n=6)。
与健康对照组相比,高狭窄组患者中 CCR7loPD-1hiefficient-cTfh 的频率明显更高(p=0.003),且与低密度脂蛋白(LDL;p=0.043)、胆固醇(p=0.043)、甘油三酯(p=0.019)、中性粒细胞计数(p=0.032)、血小板计数(p=0.024)、中性粒细胞/淋巴细胞比值(NLR;p=0.046)和血小板/淋巴细胞比值(PLR;p=0.025)呈正相关。与高狭窄组相比,健康对照组中 CCR7hiPD-1lo 静止型 cTfh 的频率更高(p=0.001),且与高密度脂蛋白(p=0.046)呈正相关。高效 cTfh 细胞的频率与血小板计数(p=0.043)、NLR(p=0.036)和 PLR(p=0.035)呈正相关,而静止型 cTfh 细胞的频率与 LDL(p=0.034)、胆固醇(p=0.047)、血小板计数(p=0.032)和 PLR(p=0.041)呈负相关。
在进展性动脉粥样硬化患者中,cTfh 和高效 cTfh 细胞的比例较高,且与血脂异常和白细胞计数相关,提示在炎症和脂质谱改变的环境中,cTfh 亚群发生了向高效表型的持续偏差。高效 cTfh 细胞具有效应细胞表型,可能反过来促进动脉粥样硬化的进展。